Cargando…
Renal asymmetric dimethylarginine inhibits fibrosis
Chronic kidney disease (CKD) is a worldwide public health problem that is caused by repeated injuries to the glomerulus or renal tubules. Renal fibrosis commonly accompanies CKD, and it is histologically characterized by excessive deposition of extracellular matrix proteins, such as fibronectin and...
Autores principales: | Wu, Ming, Yuan, Meijie, Wang, Yanzhe, Tan, Bo, Huang, Di, Wang, Chen, Zou, Yun, Ye, Chaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530377/ https://www.ncbi.nlm.nih.gov/pubmed/32794631 http://dx.doi.org/10.1002/2211-5463.12949 |
Ejemplares similares
-
Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
por: Wang, Yanzhe, et al.
Publicado: (2022) -
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4
por: Wang, Yanzhe, et al.
Publicado: (2023) -
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
por: Xu, Lin, et al.
Publicado: (2021) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)